Kidswell Bio Corporation (4584) Other
Market cap
¥12B
P/E ratio
KidsWell Bio develops biosimilar drugs and regenerative medicine treatments using SQ-SHED stem cells from baby teeth for pharmaceutical partners and rare disease patients.
| 2012/03 | 2013/03 | 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Return on Assets | - | - | - | - | -24.4 | -8.6 | -11.6 | -10.7 | -12.6 | -8.8 | -11.9 | -12.5 | -15 | 2.8 |
| Return on equity (%) | - | - | - | |||||||||||
| Employees | 8 | 8 | 13 | 14 | 19 | 20 | 21 | 26 | 45 | 39 | 38 | 41 | 42 | 37 |